A r t i c l e s Four members of the human CD1 system, CD1a, CD1b, CD1c and CD1d, bind and present diverse lipids from mammalian cells and bacteria. It is therefore thought that the CD1 system allows T cells to survey CD1-expressing antigen-presenting cells (APCs) for changes in lipid content caused by infection, inflammation or malignancy. This view is supported by several types of experimental studies. A particular subpopulation of CD1-restricted T cells, known as invariant natural killer T cells (NKT cells), was discovered on the basis of their expression of conserved T cell antigen receptors (TCRs) with limited variable region β-chains (V β ) 1 or α-chains (V α ) 2,3 . CD1d tetramers specifically bind the invariant TCRs of NKT cells, so the TCR serves as a defining surface marker that allows effector functions to be tracked and measured on a single-cell or population basis [4] [5] [6] [7] . Also, germline deletion of CD1d or the joining segment of the invariant V α chain allows selective deletion of NKT cells 8, 9 , so the influence of NKT cells in mouse models of autoimmunity, infection, tumor growth and other diseases has been broadly assessed 10 . These approaches have led to the conclusion that invariant NKT cells are preprimed memory T cells that secrete large amounts of interferon-γ (IFN-γ) and work directly or through modulation of NK cells or dendritic cells (DCs) to control infection and promote tumor regression 10 . However, for the remainder of CD1drestricted T cells that do not express the invariant TCR or for T cells that recognize the CD1 proteins in group 1 (CD1a, CD1b and CD1c), there are no broadly useful cell surface markers or genetic means of deletion. Therefore, most insight into the immunological functions of diverse CD1-restricted T cells is limited to observations of long-term T cell clones.
The evolution of gene families encoding CD1 proteins in mammals suggests that human CD1a, CD1b and CD1c proteins and their nonhuman orthologs have important roles in the immune response. Although muroid rodents lack orthologs of CD1a, CD1b or CD1c, nearly all mammalian genomes have one or more genes encoding CD1a, and no mammalian species is known to have survived without genes encoding CD1 proteins [11] [12] [13] . The retention of large gene families encoding CD1 proteins in most mammals suggests that each type of CD1 protein has a nonredundant and physiologically important role 14 . That evolutionary hypothesis is supported by molecular and cellular evidence showing that CD1a, CD1b, CD1c and CD1d differ in their transcriptional regulation 15 , patterns of tissue expression 16 , subcellular trafficking 17 and antigen groove size 18 .
Whether the differences in tissue distribution or cell biology of each CD1 protein translate into functional differences in the responding T cell populations is unknown. Two decades after the identification of human CD1-autoreactive T cells 19 , nearly all insight into their functions has been inferred from several T cell clones or lines rather than direct measurement of polyclonal T cells from blood and tissues. Clonal analysis has been successful in assigning certain unchanging aspects of phenotype, such as TCR structure, expression of the CD4 and CD8 coreceptors 20, 21 , antigens recognized 22 and molecular mechanisms of activation 18, 23 . However, long-term culture of human T cells promotes the selective outgrowth of clones with in vitro growth advantages that are probably not representative of in vivo repertoires. This longstanding and basic gap in knowledge persists because of limitations of even the best available reagents for tracking fresh polyclonal T cells, especially CD1-autoreactive T cells. Autoreactivity is a key feature of CD1-restricted T cells that probably represents their ability to recognize endogenous lipid antigens 19, [24] [25] [26] [27] . Lipid self antigens have been identified 22 , but the extent to which any one antigen can be used to track the larger pool of autoreactive T cells is unknown. In addition, tracking of autoreactive T cells with natural antigens loaded onto CD1 tetramers has been limited, because weak self agonists generally do not reliably confer adequate avidity to allow staining of TCRs 28 .
We sought to overcome those problems by designing a system in which the cells provide a diverse pool of lipid antigens for loading onto CD1. For the study of genetically diverse humans, a second design consideration was to minimize or remove the normally strong alloreactive responses to major histocompatibility complex (MHC) class I and II proteins that would confound CD1-reactive responses. We transfected plasmids encoding human CD1 molecules into human myelogenous leukemia cells (K562 cells) that have low to absent expression of MHC 29, 30 , which resulted in APCs that can be universally used with MHC-mismatched subjects. These cells presumably express a wide array of self lipid antigens, which allows broad detection of CD1 autoreactivity without prior knowledge of antigen structures. This method detected stronger and more frequent responses to CD1a than to any other human CD1 antigen-presenting molecule. Consistent with the hypothesis that each type of CD1 protein has distinct immunological functions, we found that CD1a-autoreactive T cells were fundamentally different from CD1d-reactive invariant NKT cells on the basis of their TCR patterns and effector functions. Furthermore, CD1a-autoreactive T cells expressed skin-homing markers and could be isolated from the skin and activated by epithelial CD1a-expressing Langerhans cells (LCs). Our studies identify CD1a-autoreactive cells as a subset of the human T cell repertoire and define CD1a as a target of cells of the T H 22 helper T cell subset, which suggests a new model of LC-T cell interactions in epithelial homeostasis.
RESULTS

CD1a-autoreactive T cells in peripheral blood
CD1 autoreactivity is defined as the specific recognition of CD1 in the absence of exogenous lipid antigen. Studies of CD1d-reactive NKT cells and CD1a-, CD1b-and CD1c-restricted T cell clones suggest that autoreactivity involves the recognition of an endogenous lipid antigen presented by a CD1 protein 19, 31, 32 . To study human CD1-reactive T cells, we developed a system that can measure the CD1 autoreactivity of nonclonal T cell populations ex vivo. Using K562 cells with low surface density of MHC proteins, we transfected genes encoding CD1a, CD1b, CD1c or CD1d; this resulted in high surface expression of these proteins ( Fig. 1a) . APCs transfected with an empty vector control (mock transfection) activated random donor human T cells at a frequency of approximately 1 in 10,000 ( Supplementary Fig. 1) , which confirmed the low MHC-alloreactive potential of these APCs. We confirmed the T cell-activating function of each transfected CD1 molecule by the presentation of known exogenous lipid antigens to CD1-restricted control T cell lines ( Fig. 1b) . To determine whether CD1-restricted T cells can be detected in human peripheral blood, we analyzed blood from 14 blood donors. After one or two in vitro stimulation(s) with autologous DCs expressing CD1a, CD1b, CD1c or CD1d, we assessed the CD1 reactivity of polyclonal T cells by enzymelinked immunospot (ELISPOT) assay of IFN-γ secretion, using CD1transfected K562 cells as APCs ( Fig. 1c) . We considered donor T cells to be CD1 autoreactive when the number of spots generated after contact with CD1-transfected K562 cells was significantly greater than the background response to mock-transfected K562 cells, as assessed by Fig. 2 ) or antigen specific ( Fig. 1b) In addition, we found that K562 cells transfected with a plasmid encoding CD1b (K562-CD1b cells) presented C80 GMM (data not shown), an antigen presented only after endosomal recycling 33 ; this indicated that K562 cells can survey endosomal antigens. Notably, 14 of 14 donors responded to K562-CD1a cells, and the mean responses were significantly greater than those to CD1b, CD1c or CD1d (P < 0.01, Dunnett's Multiple Comparison Test after one-way analysis of variance (ANOVA)). Unlike NKT cells, CD1a-autoreactive T cells have not been described at the polyclonal level 4,5 , so we undertook a series of analyses aimed at confirming the molecular target of recognition and more accurately measuring the frequency of responding cells. In a subset of five donors, we expanded populations of responding T cells in the presence of DCs and tested the restriction of the resulting shortterm T cell lines with K562-CD1a cells in the presence or absence of a CD1a-blocking monoclonal antibody (mAb). In all cases, the responses required CD1a on the APCs and were blocked to background expression with mAb to CD1a ( Fig. 2a) , which indicated that the responses were dependent on CD1a and not on other cell surface determinants. Next we analyzed clonal precursor frequency ex vivo in a separate group of 14 donors using autologous DCs as stimulator cells. We generated a panel of 1,291 T cell clones that detectably proliferated in response to autologous DCs and determined what percentage of autoreactive T cell clones secreted interleukin 2 (IL-2) in response to the K562-CD1a cells relative to mock transfectants ( Fig. 2b) . We found that 1 in every 50 autoreactive T cell clones, in samples from 12 of 14 donors, was CD1a autoreactive (Fig. 2c) . The first reported CD1a-autoreactive T cell clone expressed an αβ TCR and lacked expression of the CD4 and CD8 coreceptors 19 , but subsequent examples of CD1a-autoreactive T cell clones have shown CD8 expression 34 . Among the 12 clones that we were able to unambiguously analyze for coreceptor expression, we found 11 CD4 + single-positive clones, 1 CD8 + single-positive clone and no CD4 − CD8 − clones.
Invariant NKT cells that recognize CD1d are defined by TCR α-chains that contain V α 24 and α-chain joining region 18, but it is unknown whether T cells that recognize CD1a are conserved or diverse, because only two V α and V β pairs have been reported 27 . Sequencing of the TCR αand β-chains showed that none of the CD1a-reactive clones expressed the invariant V α 24 (TRAV10) or V β 11 (TRBV25) found on human NKT cells. Although several CD1aautoreactive clones shared the same variable regions and even joining regions in the TCRα or TCRβ chain, none of the clones expressed identical complementarity-determining region 3 (CDR3) sequences (data not shown). We conclude that CD1a-autoreactive T cells are CD1a common in the peripheral blood of humans and do not have the highly conserved TCR sequences seen in invariant NKT cells. Because CD1a-autoreactive T cells were abundant in these cultures, we hypothesized that they might be a preprimed T cell population that was detectable without expansion by autologous DCs. By IFN-γ ELISPOT assay, we detected responses to K562-CD1a cells in purified CD45RO + memory T cells in eight of eight random donors (Fig. 3) , and antibody-blocking experiments showed that CD1a was necessary and sufficient for the response in all cases. On the basis of the fraction of the response blocked by mAb to CD1a relative to that blocked by control immunoglobulin G (IgG), we estimated the frequency of CD1a-autoreactive T cells among peripheral blood memory T cells to be between 0.02% and 0.4%. However, this could have been an underestimate, given that not all CD1a-reactive T cells may produce IFN-γ. In agreement with our prior analysis with DC-stimulated peripheral blood mononuclear cells (PBMCs; Fig. 1c ), this ex vivo analysis of unexpanded cell populations showed that T cell responses to CD1a were of greater magnitude than those to other isoforms of CD1 (Supplementary Fig. 3) . Collectively, these results showed that CD1a-autoreactive T cells were abundant in the blood without immune stimulation and were present in most or all donors, so they can be considered to constitute a subset of the normal human αβ T cell repertoire.
Homing of CD1a-autoreactive T cells to the skin
The expression of CD1a in humans is restricted to thymocytes, myeloid DCs and LCs. In the periphery, CD1a is found predominantly in the skin, where epidermal LCs express CD1a at extremely high cell surface density 35 . Given their high cellular density and large surface area 36 , LCs form a nearly contiguous network of high-density CD1a-containing membranes in the epidermis 37 . The localization of CD1a in the skin led us to hypothesize that CD1a-autoreactive T cells in the peripheral circulation might normally home to and localize in the skin. We first determined whether CD1a-autoreactive T cells recovered from the blood expressed skin-homing markers. Because the surface expression of homing markers is rapidly altered during in vitro culture 38 , we sorted peripheral blood T cells ex vivo immediately after isolation on the basis of their expression of the memory marker CD45RO and cutaneous lymphocyte antigen (CLA), a carbohydrate epitope that identifies T cells that participate in immune responses in the skin 39 .
For this experiment we took advantage of the serendipitous finding that donor 8 had a CD1a-autoreactive T cell clone that was isolated from each of three samples, which indicated that these cells had undergone clonal expansion in vivo. We confirmed the clonality by the expression of identical TCRα and TCRβ chains in each of the isolates and also because this clone had two rearranged TCRα chains, one of which had a CDR3 out of frame (data not shown). After validating clonotypic primers for the αand β-chain of this TCR, we were able to measure the presence of this CD1a-specific clone in the naive T cell fraction (CD45RO − CLA − ), memory T cell fraction (CD45RO + CLA − ) and skin-homing memory T cell fraction (CD45RO + CLA + ) of the peripheral blood. We found PCR products for the clonotypic primers almost exclusively in the CD45RO + CLA + fraction (Fig. 4) , which indicated that in this donor, CD1a-reactive T cells were CLA + memory T cells and further suggested that CD1areactive T cells can be part of the skin-homing T cell subset.
CD1a-dependent IL-22 production
Published studies have described CD1a-autoreactive T cell clones mainly in the context of pathological conditions associated with autoimmunity 31, 32 or allergy 40 . However, the detection of polyclonal T cells that recognized CD1a among many human blood donors suggested that they fulfill some physiological function without immune provocation or dysregulation. Lacking precedent for possible effector functions associated with CD1a-autoreactive T cells, we initially screened for the possible existence of a repertoire using IFN-γ ( Fig. 1) and IL-2 (Fig. 2) , because these are somewhat promiscuously produced by T cell subsets and so increased the chance of discovering the repertoire. We next screened a broader panel of cytokines that might provide hints at specific effector functions. We tested for candidate cytokines associated with the T helper type 1 (T H 1), T H 2 and IL-17-producing (T H 17) subsets of the MHC-restricted repertoire, as well as cytokines produced by CD1d-restricted NKT cells. The dominant cytokine normally produced by NKT cells activated with synthetic or foreign antigens is IFN-γ. However, autoreactive NKT cell responses to endogenous antigens can show a broader profile, including granulocyte-macrophage colony-stimulating factor and IL-13 in the absence of IL-2 (refs. 10,41).
We stimulated CD1a-reactive T cell lines with K562-CD1a cells and measured cytokine mRNA by real-time PCR. To ensure that CD1a was both necessary and sufficient to induce measured responses, we compared the mRNA produced in response to K562-CD1a cells treated with control IgG with the mRNA produced in response to K562-CD1a cells treated with the CD1a-blocking mAb. Two of eight donors tested showed dominant upregulation of IFN-γ alone or both IFN-γ and IL-2, whereas five other donors showed an unexpected pattern characterized by a substantial upregulation of IL-22 (Fig. 5a) . We also detected secretion of IL-22 protein in a dose-dependent manner in response to CD1a (Fig. 5b) .
We considered that IL-22 might be an important effector function of the CD1a-autoreactive repertoire because this cytokine is normally restricted to a limited subset of T cells and because both IL-22 and CD1a have been suspected of having roles in skin immunity. IL-22 is a member of the IL-10 cytokine family and acts on nonhematopoietic epithelial cells, such as keratinocytes of the skin 42 , where it triggers the production of antimicrobial peptides and expression of genes involved in cellular differentiation and survival 43, 44 . It is therefore thought to be involved in early host defense against microbial pathogens and in the homeostasis of epithelia. In mice, IL-22 is often detected in T H 17 cells 45 , but human cells known as 'IL-22-only' (T H 22) helper T cells can produce IL-22 in the absence of IL-17 (refs. [46] [47] [48] [49] . In our polyclonal analysis, the lack of substantial CD1a-dependent upregulation of IL-17 mRNA in most donors suggested that these two A r t i c l e s cytokines are not coordinately upregulated in human CD1a-autoreactive T cells (Fig. 5a) . Single-cell intracellular cytokine staining showed that even a strong stimulus such as the phorbol ester PMA and ionomycin did not induce substantial production of IL-17 in two IL-22-producing CD1a-autoreactive T cell lines (Fig. 5c) , whereas the same stimulus induced the production of both cytokines in the T cell fraction of total PBMCs (data not shown). These data support the idea that IL-17 and IL-22 represent effector molecules produced by distinct T cell population in humans and that CD1a-autoreactive cells are in the IL-22-producing subset.
IL-22-producing T cell populations sometimes have a polyfunctional cytokine response, producing not only IL-17 but also IL-13, IL-2 and, in some cases, IFN-γ [47] [48] [49] . Although it was not as prominent as IL-22, IFN-γ was detectable in CD1a-autoreactive populations ( Figs. 1 and 5) , which might have been produced either by T H 1-like CD1a-restricted cells or from clones that produce both IL-22 and IFN-γ [47] [48] [49] . We found that a set of CD1a-autoreactive clones, selected on the basis of their production of IFN-γ and confirmed for clonality by V β PCR analysis, expressed either IFN-γ alone or both IFN-γ and IL-22 in various ratios in response to CD1a (Supplementary Fig. 4) .
This provided direct evidence of dual cytokine-producing CD1aautoreactive T cells at the clonal level and suggested that our earlier measurements of CD1a-dependent IFN-γ responses at the polyclonal level probably reflected both T H 1 and T H 22-T H 1 cells 49 .
Skin-homing T H 22 cells recognize CD1a
The production of IL-22 is only one feature of an emerging definition of the T H 22 helper T cell subset, which is also characterized by expression of the aryl hydrocarbon receptor 50 and expression of the chemokine receptors CCR6, CCR4 and CCR10, which promote skin homing 47, 48 . Although antigen-presenting molecules or other molecular targets recognized by T H 22 cells are not well characterized, CD1a represents a good candidate because it is located in skin, where T H 22 cells normally home. We found that CD1a-restricted T cell lines expressed the aryl hydrocarbon receptor ( Supplementary   Fig. 5 ). To directly address whether CD1a-autoreactive T cells represent a part of the T H 22 subset and their relative abundance in this subset relative to that of T H 1 or T H 17 cells, we sorted memory CD4 + T cells into the following fractions: CCR6 + CXCR3 + CCR4 − CCR10 − , CCR6 + CXCR3 − CCR4 + CCR10 − and CCR6 + CXCR3 − CCR4 + CCR10 + . The cytokine profiles measured by RT-PCR matched published results obtained by enzyme-linked immunosorbent assay 47, 48 and confirmed that these three sorted populations were enriched for T H 1, T H 17 and T H 22 cells, respectively (Fig. 6a) . After a single in vitro population expansion with DCs, we detected twofold or greater CD1a-dependent upregulation of cytokine mRNA in five of six donors. The fraction associated with T H 22 cells (CCR6 + CCR4 + CCR10 + ) showed the greatest and most frequent CD1a responses ( Fig. 6b and data not shown) . In addition, similar to our previous analysis of CD1a-autoreactive T cell cultures (Fig. 5a) , IL-2 and IL-22 were the most dominantly upregulated cytokines in CCR4 + CCR6 + CCR10 + CD4 + T cells. Thus, CD1a-autoreactive T cells are found in the human T H 22 subset, which defines CD1a as a target for T H 22 cells.
CD1a-autoreactive responses from skin
The expression of CLA and skin-homing chemokine receptors on the surface of CD1a-autoreactive T cells indicates that these cells should be present in the skin. To assess this, we isolated T cells from human skin biopsy specimens and assessed CD1a recognition 51 . Similar to results obtained with blood-derived T cells (Fig. 2c) , initial screens isolated skin T cell clones whose activation was blocked by mAb to CD1a (data not shown). We next assessed CD1a-dependent production of IL-22 in polyclonal T cells (Fig. 7a) . In two of three samples, lymphocytes isolated from normal human dermis, followed by population expansion with DCs, showed substantial IL-22 production in response to K562-CD1a cells, but not to K562-CD1b cells or K562-CD1c cells, which demonstrated the dominance of CD1a-mediated responses in healthy human skin and their ability to produce IL-22.
Expanding on the idea that CD1a-autoreactive T cells might have a role in skin immunity, we measured the ability of CD1a-autoreactive T cells to recognize natural CD1a-expressing APCs. We isolated LCs from epidermal sheets of human skin and compared them with K562-CD1a transfectants as well as monocyte-derived DCs, which mimic many features of myeloid DCs. All three cell types activated T cell lines in a CD1a-dependent manner, with the highest potency of activation using LCs (Fig. 7b) . Similar to K562-CD1a cells, LCs induced considerable upregulation of IL-22 in the absence of substantial upregulation of either IFN-γ or IL-17 (Fig. 7c) , which indicated that the pattern of CD1a-dependent induction of cytokine-encoding genes was similar when either K562 cells or freshly isolated LCs were used as stimulator cells.
DISCUSSION
More so than the T cells of other organs, T cells that reside in the skin have repertoires that differ fundamentally between mice and humans. For example, mouse skin contains large numbers of γδ T cells with V γ 5 + V δ 1 + invariant TCRs, known as dendritic epidermal T cells, whose development requires Skint1, a immunoglobulin-like dermal protein 52 . Human skin lacks Skint1 and dendritic epidermal T cells and instead contains predominantly T cells that express rearranged αβ TCRs 53, 54 . During the evolution of muroid rodents, a break in chromosome 1 resulted in a loss of genes encoding CD1 proteins of group 1, so human skin, but not mouse skin, contains LCs that express CD1a at very high density 13 . These general observations highlight two key reasons for developing experimental systems for studying skin T cell immunity in humans. First, the natural functions of CD1a cannot be studied in unmodified mice. Second, CD1a and other receptors of the immune response, which naturally differ between these two species, represent candidate molecules for controlling the dichotomously different organization of skin T cell populations seen in these species.
Although overexpression of Notch results in production of IL-22 in the absence of IL-17 (ref. 55) , mice typically secrete IL-22 in tandem with IL-17, and such double cytokine production is usually understood as a hallmark of the T H 17 helper T cell subset 56 . Human αβ T cells that produce IL-22 in the absence of IL-17 have been frequently 46, 49 . More generally, our data have shown that populations of CD1a-autoreactive T cells were abundantly present in the blood and skin of most human donors tested, so we conclude that they are a normal part of the human αβ T cell repertoire.
The experimental system we have generated is unbiased in the sense that it is able to detect responses to any CD1 protein, but T cell activation by CD1a dominated in magnitude of response and the percentage of people whose blood-and skin-derived T cells responded. An obvious possibility that would explain these findings is that CD1aautoreactive T cells may be as common as or more common than T cells that recognize other CD1 isoforms in unchallenged human hosts. The estimated precursor frequency for CD1a-autoreactive T cells among memory T cells in the blood measured here with CD1aexpressing cells (0.02% to 0.4%) is similar to that found for human NKT cells measured with CD1d-α-galactosylceramide tetramers (undetectable to 1.0%) 5, 7 . Tetramer-based detection of NKT cells is direct, but this approach necessarily requires a priori knowledge of antigens, measures responses to only one antigen and typically uses the synthetic superagonist α-galactosyl ceramide. The detection system reported here differs in that it presumably measures responses to diverse and natural cellular self antigens, a speculation supported by data showing that lipid extracts of K562 cells activate CD1a-autoreactive T cells (data not shown). Given the incomplete understanding at present of the diversity of self antigens for CD1 proteins, the features of this detection system are not only desirable but also necessary for global measurement of CD1 autoreactivity ex vivo in humans.
However, because the detection method described above requires an activation response, the number of cells detected depends on the activation threshold. Therefore, the second possibility for the detection of more CD1a-autoreactive cells is that they have a lower threshold of activation than do T cells that recognize other CD1 proteins. Because CD1a is generally absent from or low in abundance in peripheral blood and tissues other than skin, contact of CD1a-autoreactive T cells with CD1a-expressing APCs is not expected to be a common event in the blood or most other tissues. This situation contrasts with that for CD1d, which is expressed on the peripheral blood B cells, monocytes and other cells in blood and tissues 16 . These considerations suggest a model in which CD1a-reactive T cells might have low intrinsic resistance to activation. Their function may be controlled by their direct access to CD1a-expressing APCs in specialized tissue environments such as the skin.
Three related observations suggest that recognition of CD1a occurs as a mechanism of skin homeostasis: restriction of CD1a expression to the skin; homing receptors (CLA, CCR6, CCR4 and CCR10) that drive T cells to the skin; and linkage of CD1a autoreactivity to the T H 22 phenotype. Rather than stimulating other hematopoietically derived immune cells, IL-22 acts on heterodimers of the receptors IL-10R2 and IL-22R1 expressed on epithelial cells, including keratinocytes 42 . Therefore, secretion of IL-22 resulting from chronic interactions with CD1a-autoreactive TCRs on LCs might promote remodeling of the epithelial matrix in a baseline state without necessarily eliciting broader immune activation or immunopathology 44 . However, strong activation of CD1a autoreactivity is expected to cause overproduction of IL-22, which promotes the acanthosis observed in psoriasis 57 . Also, other cytokines released by CD1a-autoreactive cells (IL-2, IL-13 and IFN-γ) can promote immunopathology. These considerations drive ongoing efforts to understand the regulation of such baseline CD1a autoreactivity. Our preliminary data suggest that CD1a-autoreactive T cells are present in dermis (as reported here, and data not shown), yet LCs localize mainly to the epidermis. Therefore, one model is that these near neighbors cross the dermalepidermal junction to contact and activate each other. Also, skin is a rich source of tissue-specific oils and waxes that might function as CD1a-presented lipid autoantigens.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
